Brief: Cns Provides FDA Update On Ind Filing
Aug 25 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* CNS PROVIDES FDA UPDATE ON IND FILING
* CNS PHARMACEUTICALS INC - ANTICIPATES INITIATING CLINICAL
TRIALS
IN EARLY 2021 FOR BERUBICIN
* CNS PHARMACEUTICALS INC - EFFORTS POSITION CO TO SUBMIT AN
IND
FOR BERUBICIN IN Q4 OF THIS YEAR
Source text for Eikon: ID:nPn2pPRz9a
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026